WORXE Worlds Online Inc

MariMed and Legendary Emack & Bolio’s Launch New Line-Up of Cannabis Infused Ice Creams

MariMed and Legendary Emack & Bolio’s Launch New Line-Up of Cannabis Infused Ice Creams

NORWOOD, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) --   (CSE: MRMD), (OTCQX: MRMD), ("MariMed" or the "Company"), a leading multi-state cannabis operator focused on improving lives every day, today announced the availability of a new and scrumptious cannabis-infused ice cream. MariMed collaborated with the legendary Boston ice cream brand Emack & Bolio’s® to develop and market new and innovative vegan and dairy ice cream in outrageous flavors. The ice cream is an extension of MariMed’s top-selling and award-winning Betty’s Eddies infused fruit chews brand and shares the brand’s commitment to being hand-crafted and using all-natural ingredients.

The ice cream contains MariMed’s superior formulations of full spectrum cannabis oil, with natural cannabinoids and terpenes. Two delicious vegan flavors, Cup O’ Coffee Chip and Chocolate Sunny Days, debuted at MariMed’s Panacea Wellness dispensary in Middleborough, MA, this week. Additional flavors and wider availability are expected in the coming months.

MariMed Chief Operating Officer Tim Shaw said, “We pushed ourselves to make our infused cannabis ice cream as delicious as the best-tasting, non-infused products found in local specialty ice cream stores. With thanks to the Emack & Bolio’s ice cream magicians and our own rock star team, this new ice cream exceeds that high quality benchmark. It’s out-of-this-world delicious.”

Emack & Bolio’s was founded in 1975 by Boston music attorney Bob Rook as a place for his rock star clients to satisfy their midnight munchies after their late-night gigs. Aerosmith, Boston, U2, James Brown and The Cars were some of the groups Rook worked with back in the day. Emack & Bolio’s has evolved into a cult favorite in its specialty ice cream stores in the United States and in stores around the world.

“Working on this collaborative project of perfecting our vegan and dairy ice creams with cannabis has been so much fun,” said CEO and Creator of Emack & Bolio’s Bob Rook. “Lots of testing and of course tasting. Finally, a clean ingredient, great tasting product that’s chill. I am very happy for our fans to now try this exceptional product.”

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit .

For More Information, Contact:

Media Contact:

Trailblaze PR

Email:

Company Contact:

Howard Schacter, Chief Communications Officer

Email:

Investor Relations Contact:

Steve West, Vice President, Investor Relations

Email:

A photo accompanying this announcement is available at



EN
04/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Extends Series B Preferred Stock Obligation Through 2031, Stre...

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”). The restructuring extends the maturity of the Company’s obligations on favorable market term...

 PRESS RELEASE

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s S...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing Fun NORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and d...

 PRESS RELEASE

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand ...

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrast...

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch